Aldeyra Therapeutics, Inc. Operating Lease, Liability, Current
Financial Statements › Balance Sheet › Liabilities › Leases
us-gaap:OperatingLeaseLiabilityCurrent · last filed 2026-08-06
- 2026-06-30: Operating Lease, Liability, Current $143.45K.
- 2026-03-31: Operating Lease, Liability, Current $212.77K.
- 2025-12-31: Operating Lease, Liability, Current $280.54K.
- 2025-09-30: Operating Lease, Liability, Current $271.95K.
| Period end | Operating Lease, Liability, Current |
|---|---|
| 2026-06-30 | $143.45K 10-Q · filed 2026-08-06 |
| 2026-03-31 | $212.77K 10-Q · filed 2026-05-07 |
| 2025-12-31 | $280.54K 10-Q · filed 2026-08-06 |
| 2025-09-30 | $271.95K 10-Q · filed 2025-11-05 |
| 2025-06-30 | $263.55K 10-Q · filed 2025-08-07 |
| 2025-03-31 | $255.34K 10-Q · filed 2025-05-14 |
| 2024-12-31 | $271.63K 10-K · filed 2026-02-27 |
| 2024-09-30 | $263.24K 10-Q · filed 2024-11-07 |
| 2024-06-30 | $255.04K 10-Q · filed 2024-08-01 |
| 2024-03-31 | $247.02K 10-Q · filed 2024-05-02 |
| 2023-12-31 | $239.18K 10-K · filed 2025-02-28 |
| 2023-09-30 | $65.63K 10-Q · filed 2023-11-03 |
| 2023-06-30 | $129.78K 10-Q · filed 2023-08-03 |
| 2023-03-31 | $190.20K 10-Q · filed 2023-05-04 |
| 2022-12-31 | $249.26K 10-K · filed 2024-03-07 |
| 2022-09-30 | $184.60K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $242.64K 10-Q · filed 2022-08-05 |
| 2022-03-31 | $236.05K 10-Q · filed 2022-05-05 |
| 2021-12-31 | $229.61K 10-K · filed 2023-03-09 |
| 2021-09-30 | $222.16K 10-Q · filed 2021-10-28 |
| 2021-06-30 | $118.40K 10-Q · filed 2021-08-05 |
| 2021-03-31 | $175.62K 10-Q · filed 2021-05-06 |
| 2020-12-31 | $233.31K 10-K · filed 2022-03-17 |
| 2020-09-30 | $58.72K 10-Q · filed 2020-11-05 |
| 2020-06-30 | $116.12K 10-Q · filed 2020-08-06 |
| 2020-03-31 | $172.24K 10-Q · filed 2020-05-07 |
| 2019-12-31 | $226.33K 10-K · filed 2021-03-11 |
| 2019-09-30 | $218.95K 10-Q · filed 2019-11-07 |
| 2019-06-30 | $211.74K 10-Q · filed 2019-08-09 |
| 2019-03-31 | $221.11K 10-Q · filed 2019-05-10 |